{"id":"https://openalex.org/W2930380267","doi":"https://doi.org/10.1177/1934578x0800300105","title":"Boswellic Acids with Acetylcholinesterase Inhibitory Properties from Frankincense","display_name":"Boswellic Acids with Acetylcholinesterase Inhibitory Properties from Frankincense","publication_year":2008,"publication_date":"2008-01-01","ids":{"openalex":"https://openalex.org/W2930380267","doi":"https://doi.org/10.1177/1934578x0800300105","mag":"2930380267"},"language":"en","primary_location":{"id":"doi:10.1177/1934578x0800300105","doi":"https://doi.org/10.1177/1934578x0800300105","is_oa":false,"landing_page_url":"https://doi.org/10.1177/1934578x0800300105","pdf_url":null,"source":{"id":"https://openalex.org/S124250138","display_name":"Natural Product Communications","issn_l":"1555-9475","issn":["1555-9475","1934-578X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","jufo-1","norway-1","oarl","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Natural Product Communications","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doaj.org/article/472df83bd21f4540969edf4e9a7c2a54","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Masahiro Ota","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]},{"id":"https://openalex.org/I4210123820","display_name":"Shiseido Group (Japan)","ror":"https://ror.org/03da3g825","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210123820"]}],"countries":["GB","JP"],"is_corresponding":false,"raw_author_name":"Masahiro Ota","raw_affiliation_strings":["Pharmaceutical Sciences Research Division, King's College London, 150 Stamford St, London, SE1 9NH, UK","Shiseido Life Science Research Center, 2-2-1 Hayabuchi, Tsuzuki-ku, Yokohama-shi, 224-8558, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Sciences Research Division, King's College London, 150 Stamford St, London, SE1 9NH, UK","institution_ids":["https://openalex.org/I183935753"]},{"raw_affiliation_string":"Shiseido Life Science Research Center, 2-2-1 Hayabuchi, Tsuzuki-ku, Yokohama-shi, 224-8558, Japan","institution_ids":["https://openalex.org/I4210123820"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5073277560","display_name":"Peter John Houghton","orcid":"https://orcid.org/0000-0002-2400-8184","observed_orcids":["https://orcid.org/0000-0002-2400-8184"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Peter J. Houghton","raw_affiliation_strings":["Pharmaceutical Sciences Research Division, King's College London, 150 Stamford St, London, SE1 9NH, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Sciences Research Division, King's College London, 150 Stamford St, London, SE1 9NH, UK","institution_ids":["https://openalex.org/I183935753"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5073277560"],"corresponding_institution_ids":["https://openalex.org/I183935753"],"apc_list":{"value":2650,"currency":"USD","value_usd":2650},"apc_paid":null,"fwci":0.2241,"has_fulltext":false,"cited_by_count":16,"citation_normalized_percentile":{"value":0.65401048,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"3","issue":"1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13335","display_name":"Pharmacological Effects of Medicinal Plants","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T13335","display_name":"Pharmacological Effects of Medicinal Plants","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12530","display_name":"Bioactive Natural Diterpenoids Research","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/boswellic-acids","display_name":"boswellic acids","score":0.9950000047683716},{"id":"https://openalex.org/keywords/acetylcholinesterase-inhibition","display_name":"acetylcholinesterase inhibition","score":0.949999988079071},{"id":"https://openalex.org/keywords/frankincense","display_name":"frankincense","score":0.9779999852180481},{"id":"https://openalex.org/keywords/boswellia","display_name":"Boswellia","score":0.859000027179718},{"id":"https://openalex.org/keywords/ursane-triterpenoids","display_name":"ursane triterpenoids","score":0.8220000267028809},{"id":"https://openalex.org/keywords/11-keto-beta-boswellic-acid","display_name":"11-keto-\u03b2-boswellic acid","score":0.8600000143051147},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.8659999966621399},{"id":"https://openalex.org/keywords/bioassay-guided-fractionation","display_name":"bioassay-guided fractionation","score":0.8840000033378601},{"id":"https://openalex.org/keywords/memory-enhancement","display_name":"memory enhancement","score":0.5590000152587891},{"id":"https://openalex.org/keywords/ethyl-acetate-extract","display_name":"ethyl acetate extract","score":0.5960000157356262}],"concepts":[{"id":"https://openalex.org/C2778816929","wikidata":"https://www.wikidata.org/wiki/Q22676679","display_name":"Acetylcholinesterase","level":3,"score":0.7765665054321289},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7434924244880676},{"id":"https://openalex.org/C2779858419","wikidata":"https://www.wikidata.org/wiki/Q407153","display_name":"Ethyl acetate","level":2,"score":0.4795915186405182},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.4127257168292999},{"id":"https://openalex.org/C556039675","wikidata":"https://www.wikidata.org/wiki/Q771035","display_name":"Traditional medicine","level":1,"score":0.38214483857154846},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.2768688201904297},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.04617035388946533}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1177/1934578x0800300105","doi":"https://doi.org/10.1177/1934578x0800300105","is_oa":false,"landing_page_url":"https://doi.org/10.1177/1934578x0800300105","pdf_url":null,"source":{"id":"https://openalex.org/S124250138","display_name":"Natural Product Communications","issn_l":"1555-9475","issn":["1555-9475","1934-578X"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","jufo-1","norway-1","oarl","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Natural Product Communications","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:472df83bd21f4540969edf4e9a7c2a54","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/472df83bd21f4540969edf4e9a7c2a54","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Natural Product Communications, Vol 3 (2008)","raw_type":"article"}],"best_oa_location":{"id":"pmh:oai:doaj.org/article:472df83bd21f4540969edf4e9a7c2a54","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/472df83bd21f4540969edf4e9a7c2a54","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Natural Product Communications, Vol 3 (2008)","raw_type":"article"},"sustainable_development_goals":[{"score":0.4043000042438507,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":12,"referenced_works":["https://openalex.org/W43637279","https://openalex.org/W2000999781","https://openalex.org/W2011860269","https://openalex.org/W2022456768","https://openalex.org/W2053552819","https://openalex.org/W2060288971","https://openalex.org/W2065756284","https://openalex.org/W2070566742","https://openalex.org/W2126399705","https://openalex.org/W2129678592","https://openalex.org/W2286003492","https://openalex.org/W4231712045"],"related_works":["https://openalex.org/W2591311911","https://openalex.org/W181991702","https://openalex.org/W2889765960","https://openalex.org/W3179564189","https://openalex.org/W2389303938","https://openalex.org/W2980726184","https://openalex.org/W2050957240","https://openalex.org/W2267504622","https://openalex.org/W2342832305","https://openalex.org/W2888977223"],"abstract_inverted_index":{"Frankincense,":[0],"a":[1],"gum":[2],"resin":[3],"secreted":[4],"from":[5,41],"barks":[6],"of":[7,27,29,48,116,128],"Boswellia":[8],"species,":[9],"is":[10],"reputed":[11],"in":[12,135],"Arabian":[13],"folk":[14],"medicine":[15],"to":[16,55,110],"improve":[17],"the":[18,23,45,70,114,118,129,136],"memory.":[19],"In":[20],"this":[21],"study,":[22],"acetylcholinesterase":[24,75],"inhibitory":[25,72,107],"effect":[26],"extracts":[28,43],"frankincense":[30],"and":[31,60,80,100,127],"their":[32,61],"constituents":[33],"were":[34,63,76,104],"investigated.":[35],"The":[36,66],"ethyl":[37],"acetate":[38],"soluble":[39],"fraction":[40],"methanol":[42],"showed":[44],"greatest":[46],"inhibition":[47],"acetylcholinesterase.":[49],"Bioassay-guided":[50],"fractionation":[51],"was":[52],"carried":[53],"out":[54],"isolate":[56],"several":[57],"boswellic":[58,67],"acids,":[59],"structures":[62],"determined":[64],"spectroscopically.":[65],"acids":[68],"showing":[69],"most":[71],"activity":[73,108],"on":[74],"11\u03b1-hydroxy-\u03b2-boswellic":[77],"acid":[78,82,89,92,95,98,102],"(1)":[79],"11-keto-\u03b2-boswellic":[81],"(5),":[83],"whilst":[84],"others":[85],"isolated":[86],"i.e.":[87],"3\u03b1-acetyl-11-keto-\u03b2-boswellic":[88],"(2),":[90],"3\u03b1-acetyl-11\u03b1-hydroxy-\u03b2-boswellic":[91],"(3),":[93],"11\u03b1-methoxy-\u03b2-boswellic":[94],"(4),":[96],"\u03b2-boswellic":[97],"(6)":[99],"\u03b1-boswellic":[101],"(7)":[103],"inactive.":[105],"Acetylcholinesterase":[106],"appears":[109],"be":[111],"associated":[112],"with":[113],"presence":[115],"either":[117],"free":[119,130],"hydroxyl":[120,131],"group":[121,124,132],"or":[122],"keto":[123],"at":[125,133],"C-11":[126],"C-3":[134],"ursane":[137],"skeleton.":[138]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-04-11T00:00:00"}